Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma
about
CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25 T cellsRegulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic TargetingRole of the tumor microenvironment in mature B-cell lymphoid malignanciesLymphoma Immunotherapy: Current StatusLymphoma: immune evasion strategiesLymphomatoid granulomatosis--a single institute experience: pathologic findings and clinical correlationsPD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphomaApoptosis of CD4(+)CD25(high) T cells in response to Sirolimus requires activation of T cell receptor and is modulated by IL-2FOXP3+ Tregs and B7-H1+/PD-1+ T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapy.Phase I study of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with relapsed and refractory B-cell non-Hodgkin lymphoma.Fludarabine modulates immune response and extends in vivo survival of adoptively transferred CD8 T cells in patients with metastatic melanoma.Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1.The role of regulatory T cells in cancer.In silico analyses reveal common cellular pathways affected by loss of heterozygosity (LOH) events in the lymphomagenesis of Non-Hodgkin's lymphoma (NHL).Immunotherapy in acute leukemiaChemotherapy rescues tumor-driven aberrant CD4+ T-cell differentiation and restores an activated polyfunctional helper phenotype.Evaluation of Apoptotic Marker Bcl2, CD4+, Human Hepatocyte Growth Factor and Metalloproteinase-9 as Tumor Markers for Patients with Hepatocellular Carcinoma.Characterization of protective human CD4CD25 FOXP3 regulatory T cells generated with IL-2, TGF-β and retinoic acidIn situ prior proliferation of CD4+ CCR6+ regulatory T cells facilitated by TGF-β secreting DCs is crucial for their enrichment and suppression in tumor immunity.Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis.Th17 cells are involved in the local control of tumor progression in primary intraocular lymphoma.Regulatory T-cell depletion in angioimmunoblastic T-cell lymphoma.Dissecting the regulatory microenvironment of a large animal model of non-Hodgkin lymphoma: evidence of a negative prognostic impact of FOXP3+ T cells in canine B cell lymphoma.ProtEx technology for the generation of novel therapeutic cancer vaccinesMalignant B cells induce the conversion of CD4+CD25- T cells to regulatory T cells in B-cell non-Hodgkin lymphomaUXT is a novel regulatory factor of regulatory T cells associated with Foxp3.In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II studyProgrammed death-1 and its ligand are novel immunotolerant molecules expressed on leukemic B cells in chronic lymphocytic leukemiaPlatelet-derived growth factor (PDGF)-PDGF receptor interaction activates bone marrow-derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switch.Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial.Functionally suppressive CD8 T regulatory cells are increased in patients with multiple myeloma: a cause for immune impairment.The consequence of immune suppressive cells in the use of therapeutic cancer vaccines and their importance in immune monitoringInherited variants in regulatory T cell genes and outcome of ovarian cancer.Tregs and rethinking cancer immunotherapy.Soluble and membrane-bound TGF-β-mediated regulation of intratumoral T cell differentiation and function in B-cell non-Hodgkin lymphoma.Safety, pharmacokinetics, and immunomodulatory effects of lenalidomide in children and adolescents with relapsed/refractory solid tumors or myelodysplastic syndrome: a Children's Oncology Group Phase I Consortium report.Host defense and recruitment of Foxp3⁺ T regulatory cells to the lungs in chronic Mycobacterium tuberculosis infection requires toll-like receptor 2Tumor-infiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancerCCR4 contributes to the pathogenesis of experimental autoimmune encephalomyelitis by regulating inflammatory macrophage function.PD-1 expression defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survival
P2860
Q24681974-57C21DB8-260B-4A73-A05A-2816CE7DD261Q26742012-9AC6B2AC-2F98-48EB-8CD1-5EFFBDE2F575Q26748775-DF882E7A-7F34-440B-8B0B-8998FC4881A6Q26782902-097DC48E-1360-4F8C-936E-453A16108282Q28080705-D77E9100-DD3F-4DF1-B0FA-4122E38CDB28Q28249823-0FF303A1-6484-495F-AD7D-4492F08EDA3BQ29620878-5D0D592A-71C9-4FF6-AB2C-EC8404A97918Q30439284-0D3FF0F1-1248-4C41-886F-2FD665F0798AQ33320890-08F0620C-541D-4675-A9B8-A56DDB675A44Q33386521-4B49B5D6-F8E3-493E-8A41-FE5447C9F26EQ33416009-D77300B8-4138-4E2C-91D9-DA8D43036667Q33528964-5D637CAB-FF43-4C9C-A614-661385D39834Q33631986-2C982F31-4346-4A4B-B505-F0851C132EBBQ33701036-A765AD7C-F233-422D-B480-4CAA6A7DD82EQ33731552-A7B41D36-F1AA-4A85-A40B-A585FAF93374Q33754618-B2D38903-32C4-4410-AA62-ACDD99301951Q33774580-B3C9F78E-B24E-4B9A-8A47-2AB306D933FFQ33778359-98AA2111-8EE8-4D8D-8963-9C39758E54F5Q33927127-CF396B53-3ED1-4AAD-8025-52423E2A2C75Q34026203-294F212E-B803-4F71-B2A1-3DC3B34CD9F2Q34031403-E563D795-9CD5-478B-B4DB-FCA4D64F452AQ34033478-EE07BB57-E93D-42C2-A0CC-372D3F2EFE42Q34041661-449D2994-A68A-46D2-8CB1-54131320F7AAQ34048819-21BA99FC-CB82-4A9A-BEC8-930DDEAB57C6Q34103249-3CD6E2F6-A310-4D7E-AB8B-3A212004CD9FQ34193045-20139491-3AAE-463D-BA45-E4EFDF3CBFEFQ34194680-FA5E97AB-C23F-41A6-B502-ABA2DA50894FQ34245048-50E9B351-0A24-4BA3-B5FF-DD67096E1F41Q34282342-5FE366B8-32C2-47BF-BAF4-B3B3E45583E7Q34391446-8146ABB5-4EC9-4911-9021-82BE347AC1B8Q34478019-D4A0D9FD-367F-41B5-8E12-04FBBCD7C2B6Q34557531-66BC279B-E93E-4289-9A1E-DEE89C30CEDAQ34575290-B4D24D4D-CB59-4CAD-818D-DAC995276B29Q34625147-AB511D80-9754-4BE9-B7A2-5079EC643A6CQ34649178-707C186C-0C8A-4B5F-B9BF-3C57C7A4EFF2Q34666858-6CF99DD0-EFFA-4FA6-838C-8939B007A545Q34778481-5073BA98-22E1-4A32-8BBA-E1A70657C345Q35032491-56EAB539-9304-4427-B06D-7FF901853AA6Q35113362-BCCEA220-8BB6-4E97-A4B3-356B3E4CFC5DQ35146249-525DF3CB-3D1E-458E-8907-E2C7A03C72BE
P2860
Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Intratumoral CD4+CD25+ regulat ...... in B-cell non-Hodgkin lymphoma
@ast
Intratumoral CD4+CD25+ regulat ...... in B-cell non-Hodgkin lymphoma
@en
type
label
Intratumoral CD4+CD25+ regulat ...... in B-cell non-Hodgkin lymphoma
@ast
Intratumoral CD4+CD25+ regulat ...... in B-cell non-Hodgkin lymphoma
@en
prefLabel
Intratumoral CD4+CD25+ regulat ...... in B-cell non-Hodgkin lymphoma
@ast
Intratumoral CD4+CD25+ regulat ...... in B-cell non-Hodgkin lymphoma
@en
P2093
P2860
P1433
P1476
Intratumoral CD4+CD25+ regulat ...... in B-cell non-Hodgkin lymphoma
@en
P2093
Anne J Novak
Mary J Stenson
Stephen M Ansell
Thomas E Witzig
Zhi-Zhang Yang
P2860
P304
P356
10.1182/BLOOD-2005-08-3376
P407
P577
2006-01-10T00:00:00Z